Papers
9
Total Citations
271
H-Index
5
About
Simone Scuderi is a leading urologic surgeon and researcher whose work centers on advancing surgical precision and outcomes in prostate and bladder cancer. His primary research areas include PSMA radioguided surgery (RGS), robot-assisted radical prostatectomy (RARP), and perioperative complication reduction. Scuderi’s major contributions include pioneering the use of prostate-specific membrane antigen (PSMA) RGS to detect lymph node metastases during robot-assisted radical prostatectomy, as demonstrated in his highly cited 2022 prospective phase 2 study (94 citations). He also played a key role in evaluating surgical safety following neoadjuvant pembrolizumab in bladder cancer patients through the PURE-01 trial (69 citations). His work on defining optimal target-to-background ratios for PSMA-RGS and implementing audit-and-feedback interventions to reduce postoperative complications has shaped clinical guidelines. With over 270 citations across his most impactful papers, Scuderi’s research has directly improved nodal staging accuracy and patient outcomes. Notably, he has contributed to systematic reviews on decision regret after RARP and multimodal treatment for oligometastatic prostate cancer, underscoring his commitment to both technical innovation and patient-centered care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9